Literature DB >> 1921232

Serratia infections in patients with neutropenia.

F Hartmann1, T Gheorghiu, H Leupold, F Baer, V Diehl.   

Abstract

We report on six cases of sepsis caused by Serratia marcescens in patients with neutropenia. Four cases showed an additional involvement of the upper respiratory and digestive tract with oral and pharyngeal mucositis, haemorrhagic laryngo-tracheo-bronchitis, and oedematous swelling of the face. One patient showed a Serratia marcescens carrier state in the pharynx over a period of months without neutropenia. The isolated strains showed a broad spectrum of resistance against antibiotics; only aztreonam and amikacin were effective in vitro against all isolates.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1921232     DOI： 10.1007/bf01649421

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  11 in total

1.  Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.

Authors:  G P Bodey; D H Ho; L Elting
Journal:  Am J Med       Date:  1988-07-25       Impact factor: 4.965

2.  Oral infections associated with chemotherapy in adults with acute leukemia.

Authors:  S Dreizen; K B McCredie; M J Keating; G P Bodey
Journal:  Postgrad Med       Date:  1982-06       Impact factor: 3.840

3.  Serratia bacteremia: a review of 44 episodes.

Authors:  C Watanakunakorn
Journal:  Scand J Infect Dis       Date:  1989

4.  Serratia bacteremia: review of 118 cases.

Authors:  H Saito; L Elting; G P Bodey; P Berkey
Journal:  Rev Infect Dis       Date:  1989 Nov-Dec

5.  Pathogenic potentials of bacterial proteases.

Authors:  H Maeda; A Molla
Journal:  Clin Chim Acta       Date:  1989-12-15       Impact factor: 3.786

Review 6.  Fever and infection in leukemic patients: a study of 494 consecutive patients.

Authors:  G P Bodey; V Rodriguez; H Y Chang
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

7.  Serratia bacteremia.

Authors:  E Bouza; M García de la Torre; A Erice; E Cercenado; E Loza; M Rodríguez-Créixems
Journal:  Diagn Microbiol Infect Dis       Date:  1987-08       Impact factor: 2.803

8.  Moxalactam in nosocomial infections with Serratia marcescens.

Authors:  T Mall; F Follath; M Salfinger; R Ritz; H Reber
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

9.  Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria.

Authors:  C Thornsberry
Journal:  Am J Med       Date:  1985-08-09       Impact factor: 4.965

10.  [Nosocomial infections caused by multi-resistant Serratia marcescens at a university clinic--clinical aspects and drug resistance].

Authors:  E Halle; E L Grauel; I Klare; R Bollmann; P Buchholz; W Scholowska-Köhler; W Witte; B Göldner; B Baumann
Journal:  Padiatr Grenzgeb       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.